To assess the prognostic value of systemic arterial lactate levels in patients with ST segment elevation myocardial infarction undergoing primary PCI and correlate with the results of primary PCI and 30 days MACE follow up.
* Study Population: STEMI patients treated with primary PCI. * Study period: over 6 months. * Sample Size: 300 patients. All patients received the standard care for acute STEMI patients which is the primary percutaneous intervention in addition to medications. Hyperlactemia is defined as elevated lactic acid level in the blood. The normal blood lactate level is (0.5-1 mmol/L). All subjects were subjected to 1. Careful history taking 2. Full cardiac examination 3. Investigations include: 1. 12 lead surface ECG. 2. Lactate level and full labs 3. Pre-discharge echocardiography 4. Peri-procedural details of primary PCI the investigators assessed the relation between hyperlactemia and coronary flow, peak cardiac enzymes, hemodynamic parameters and MACE in 30 days follow up
Study Type
OBSERVATIONAL
Enrollment
300
an arterial lactate level measured from arterial sample from STEMI patients
Ahmed Maher teaching hospiral
Cairo, Elsayda Zainab Square, Egypt
Major adverse caediac events
we follow up occurrence of death, reinfarction, repeated hospitalization and new onset heart failure
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.